Fundz

Fundz Deep Dive

Everything you need to win Carney Taylor — in one platform.

Who to reach, what to say, and why now on Carney Taylor — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Carney Taylor — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Interwell Health Appoints Carney Taylor As Chief Medical Officer

PRIVATEJan 26, 20265 months ago

Position

Chief Medical Officer

Company

Interwell Health

Carney Taylor
BostonBiotechnologyHealthcareHealth CareMedical

Description

Interwell Health has named Carney Taylor, MD, MBA, as the new chief medical officer to guide clinical strategy and quality initiatives. This appointment comes as part of the company's succession plan following Dr. George Hart's retirement on January 1, 2026.

Company Information

Company

Interwell Health

Location

177 Huntington Ave Ste 1703

Boston, Massachusetts, United States

About

Interwell Health is a leading provider of value-based kidney care, dedicated to reimagining healthcare so patients with chronic kidney disease can live their best lives. Partnering with over 2,000 nephrologists, Interwell combines total patient care and provider enablement with advanced machine learning to deliver personalized treatment from stage 3 CKD to kidney failure, achieving sustainable savings and exceptional quality outcomes across all 50 states and Puerto Rico.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Interwell Health's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.